Basic Information
ID: ALA4017796
Type: Functional
Description: Antitumor activity against human NCI-H3122 cells xenografted in BALB/c nu/nu mouse assessed as tumor growth inhibition at 50 mg/kg administered once daily via oral gavage for 14 days measured twice weekly during compound dosing relative to control
Organism: Homo sapiens
Cell type: NCI-H3122
Activity Charts
Bioactivity
Activity Types for Assay ALA4017796
TGI
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 558.15 | 6.36 | 6.36 |
| 556.09 | 4.82 | 4.82 |